BSX
70
2
JPM
67
4
NSC
57
7
NTAP
66
2
CINF
51
4
JNJ
44
3
DLTR
38
4
PH
73
3
AMAT
42
6
WAT
53
6
DG
4
2
PPL
59
5
FE
52
3
SRE
66
3
FITB
60
2
VTR
54
5
SWKS
49
11
WHR
64
3
AZO
48
2
DHR
38
3
BSX
70
2
JPM
67
4
NSC
57
7
NTAP
66
2
CINF
51
4
JNJ
44
3
DLTR
38
4
PH
73
3
AMAT
42
6
WAT
53
6
DG
4
2
PPL
59
5
FE
52
3
SRE
66
3
FITB
60
2
VTR
54
5
SWKS
49
11
WHR
64
3
AZO
48
2
DHR
38
3
Financhill
Back

Eton Pharmaceuticals 10K Form

Buy
83

ETON
Eton Pharmaceuticals

Last Price:
11.19
Seasonality Move:
12.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ETON News And Ratings

See the #1 stock for the next 7 days that we like better than ETON

ETON Financial Statistics

Sales & Book Value

Annual Sales: $31.64M
Cash Flow: $2.95M
Price / Cash Flow: 1167.57
Annual Sales: $0.62
Price / Book: 17.38

Profitability

EPS (TTM): -0.22000
Net Income (TTM): $-5.48M
Gross Margin: $21.06M
Return on Equity: -35.45%
Return on Assets: -16.95%

Eton Pharmaceuticals Earnings Forecast

Key Eton Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for ETON is 66.56%.
  • The Selling, General & Administrative Expenses for ETON have been equal to 59.83% of Gross Profit Margin.
  • The Research & Development expenses have been 10.50% of Revenue.
  • The Net Earning history of ETON is -2.96% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Eton Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ETON
CUSIP: 29772L
Website: etonpharma.com

Debt

Debt-to-Equity Ratio: 0.26
Current Ratio: 1.51
Quick Ratio: 1.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 23.63

ETON Technical Analysis vs Fundamental Analysis

Buy
83
Eton Pharmaceuticals (ETON) is a Buy

Is Eton Pharmaceuticals a Buy or a Sell?